4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-25-014850
CEO & President sold 155,333 shares at $0.78 ($121,160)
- CEO & President acquired 751,407 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO & President | 2025-02-03 | Grant or award | +751,407 | 1,892,216 | D | ||
| Shukla Sath CEO & President | 2025-02-05 | Sale | −6,139 | $0.78 | $4,788 | 1,886,077 | D |
| Shukla Sath CEO & President | 2025-02-05 | Sale | −42,786 | $0.78 | $33,373 | 1,843,291 | D |
| Shukla Sath CEO & President | 2025-02-05 | Sale | −106,408 | $0.78 | $82,998 | 1,736,883 | D |
| Open-market sales · 155,333 sh · avg $0.78 · $121,160 | |||||||
Loading xslF345X05/ownership.xml…